![](/img/cover-not-exists.png)
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
Wallace, D. J., Gordon, C., Strand, V., Hobbs, K., Petri, M., Kalunian, K., Houssiau, F., Tak, P. P., Isenberg, D. A., Kelley, L., Kilgallen, B., Barry, A. N., Wegener, W. A., Goldenberg, D. M.Volume:
52
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/ket129
Date:
July, 2013
File:
PDF, 332 KB
english, 2013